B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
Observational
Observational Model: Case Control, Time Perspective: Cross-Sectional
expression of cell surface antigens HLA-DR and CD38+ markers in B-CLL cells compared to normal B-lymphocytes
samples will be taken at the beginning, week 2, 4,6,8,12,and 24 (for blood), and bone marrow samples at weeks 2 and 6.
No
Nicholas Chiorazzi, MD
Principal Investigator
North Shore-LIJ Health System
United States: Federal Government
04-046
NCT01028430
July 1998
January 2014
Name | Location |
---|---|
Feinstein Institute for Medical Research | Manhassett, New York 11030 |